|
Volume 272, Number 50, Issue of December 12, 1997
pp. 31693-31699
A Role for Estrogen-related Receptor in the Control of
Mitochondrial Fatty Acid -Oxidation during Brown Adipocyte
Differentiation*
(Received for publication, August 18, 1997, and in revised form, September 12, 1997)
Rick B.
Vega
and
Daniel P.
Kelly
§¶
From the Center for Cardiovascular Research, Departments of
§ Medicine and Molecular Biology & Pharmacology, Washington University School of Medicine,
St. Louis, Missouri 63110
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
Note Added in Proof
REFERENCES
ABSTRACT
Little is known about the factors involved in the
brown adipocyte gene regulatory program. In contrast to the white
adipocyte, the brown adipocyte is characterized by abundant
mitochondria and high level expression of mitochondrial fatty acid
-oxidation enzymes. Previous studies in transgenic mice have shown
that the brown adipose-enriched expression of a key -oxidation
enzyme, medium chain acyl-coenzyme A dehydrogenase (MCAD), requires
cis-acting elements located within the proximal promoter region of the
MCAD gene. The levels of mRNA encoding MCAD and several other
-oxidation cycle enzymes were coordinately induced during
differentiation of brown adipocytes in culture. Expression of
transgenes comprised of MCAD gene promoter fragments fused to
chloramphenicol acetyltransferase reporters in differentiating brown
adipocytes revealed that a known nuclear receptor response element
(NRRE-1) was required for the transcriptional induction of the MCAD
gene during brown adipocyte differentiation. Electrophoretic mobility
shift assays and antibody recognition studies identified distinct brown
adipocyte differentiation stage-specific, NRRE-1-protein complexes; the orphan nuclear receptors, chicken ovalbumin upstream promoter transcription factors I and II, were identified as major the NRRE-1 binding proteins in the pre-adipocyte, whereas the estrogen-related receptor (ERR ) bound NRRE-1 in extracts prepared from
differentiated brown adipocytes. DNA binding studies performed with a
series of NRRE-1 mutant probes indicated that ERR was capable of
binding two distinct sites within NRRE-1, each of which conform to the known ERR monomeric binding consensus. The expression of ERR paralleled NRRE-1 binding activities and MCAD expression during brown
adipocyte differentiation, cardiac development, and among a variety of
adult mouse tissues. These results identify a new class of ERR
target genes and implicate ERR and chicken ovalbumin upstream
promoter transcription factor in the control of a pivotal metabolic
pathway during brown adipocyte differentiation.
INTRODUCTION
In contrast to the white adipocyte, which functions mainly as a
lipid storage cell, the brown adipocyte is a specialized thermogenic cell characterized by the presence of the mitochondrial uncoupling protein (UCP).1 UCP functions
to disrupt the proton gradient across the inner mitochondrial membrane
resulting in the "uncoupling" of oxidative phosphorylation and
dissipation of energy as heat. Evidence is emerging that in addition to
thermogenesis, brown adipose tissue (BAT) plays a pivotal role in
mammalian whole body energy homeostasis and control of body weight
(1-4). Fatty acid -oxidation provides the reducing equivalents for
the mitochondrial uncoupling reaction. Thus, flux through the
-oxidation cycle is one important determinant of the rate of
uncoupling of oxidative phosphorylation in a given tissue. The majority
of cellular fatty acid oxidation occurs in the mitochondria via a
four-step cycle catalyzed by nuclear-encoded enzymes (5). The
expression of mitochondrial fatty acid oxidation enzymes is very high
in BAT and other tissues with high oxidative energy demands, such as
heart. Accordingly, in contrast to the white adipocyte, the brown
adipocyte has abundant mitochondria and a high capacity for fatty acid
oxidation.
Little is known about the brown adipocyte differentiation program or
about the molecular regulatory factors that distinguish BAT from white
adipose tissue. Recently, several factors involved in the general
adipocyte program have been elucidated. The peroxisome proliferator-activated receptor (PPAR ), a member of the nuclear receptor transcription factor superfamily, plays a pivotal role in
adipocyte differentiation. In the presence of activators of PPAR ,
ectopic overexpression of this nuclear receptor has been shown to
trigger the adipocyte program in a variety of cells, including
non-adipocytes (6, 7). Members of the C/EBP family of transcription
factors have also been shown to be critical components of the
adipogenic differentiation program (8, 9). These factors, however, are
common to the brown and white adipocyte and, thus, are unlikely to
account for the biochemical and structural differences between the two
cell types.
To understand the molecular regulatory mechanisms involved in the
control of the mitochondrial -oxidation pathway in BAT and as an
initial step toward the elucidation of the factors involved in the
brown adipocyte differentiation program, we have begun to dissect the
regulatory pathway controlling expression of genes encoding
mitochondrial fatty acid oxidation enzymes in BAT. To this end, we have
focused on the nuclear gene encoding, medium chain acyl-coenzyme A
dehydrogenase (MCAD) (2,3-oxidoreductase, EC 1.3.99.3), a pivotal
enzyme in the mitochondrial fatty acid -oxidation cycle. These
studies revealed that a complex nuclear receptor response element
(NRRE-1), located in the proximal region of the human MCAD gene
promoter, is required for high level transcription of a reporter gene
in BAT and heart in adult transgenic mice (10). Studies performed
in vitro have shown that NRRE-1 is a pleiotropic element
capable of conferring transcriptional activation via several nuclear
receptors including the retinoid X receptor (RXR) and PPAR (11) or
repression by the orphan receptors chicken ovalbumin upstream promoter
transcription factors I and II (COUP-TF I and II; Ref. 12). However,
the endogenous nuclear receptors that interact with NRRE-1 in the brown
adipocyte in vivo have not been identified.
In this report we demonstrate that NRRE-1 is necessary for the
transcriptional induction of the MCAD gene during brown adipocyte differentiation in culture and describe the identification of two
endogenous nuclear receptors that bind NRRE-1. NRRE-1 is shown to
interact with COUP-TF I and II in the pre-brown adipocyte, whereas the
orphan receptor estrogen-related receptor or ERR binds NRRE-1 in
the differentiated brown adipocyte. Moreover, we show that the
expression of ERR during brown adipocyte differentiation and among
mouse tissues parallels MCAD expression and the known tissue-specific
differences in -oxidation rates. These results implicate members of
the nuclear receptor superfamily in a pivotal brown adipocyte metabolic
gene regulatory program and identify a potential role for ERR in the
control of mitochondrial fatty acid oxidation.
MATERIALS AND METHODS
Primary Brown Adipocyte Isolation and Culture
Brown
pre-adipocytes were isolated from the interscapular brown fat pads of
3-4-week-old C57Bl/6xSJL mice as described (13). In brief, the fat
pads were removed and digested with collagenase. The digested tissue
was sequentially passed through 250- and 60-µm nylon filters. The
filtrate was centrifuged at 800 × g to pellet the
stromal vascular cell fraction. The cells were grown in Dulbecco's modified Eagle's medium/F-12 (Cellgro, Mediatech) plus 10% fetal calf
serum. On day 3 of culture, one-half of the media was removed and
replaced with differentiation media containing 20 nM
insulin and 2 nM triiodothyronine. On day 9, all of the
media was replaced with fresh differentiation media. The cells were
originally plated at a density such that confluency was reached by day
6. Using this approach, greater than 75% of the cells were
differentiated by day 10. The cells were judged to be differentiated
based on the appearance of multilocular lipid droplets and a marked
increase in mitochondrial size and number as judged by light and
electron microscopy.
Northern Blot Analysis
Total RNA was isolated from brown
adipocytes in culture using the RNAzol (Tel-Test, Inc.) method.
Northern blot analysis was performed as described (14) using cDNA
probes labeled to high specific activity via the random-primed labeling
technique. Probes used included a mouse MCAD cDNA (10), a rat long
chain acyl-CoA dehydrogenase cDNA (a gift from Dr. Bryan Hainline,
Indiana University), a cDNA encoding human subunit of 3-OH long
chain acyl-CoA dehydrogenase, (a gift from Dr. Arnold Strauss,
Washington University), and a PPAR cDNA (a gift from Dr. Jeff
Gimble, Oklahoma Medical Research Foundation). An 18 S rRNA probe
signal was used as a control for loading amounts.
Transgenic Mice and CAT Assays
The MCADCAT.371 and
MCADCAT NRRE-1 transgenic mouse lines have been described (10). CAT
activity assays were performed with protein extracts prepared from
primary brown adipocytes isolated from pooled litters of 21-day-old
MCADCAT.371 (line 10-1) and MCADCAT NRRE-1 mice (line 11-3) as
described (10). In brief, cells were harvested at the indicated time
points using a commercial lysis buffer per manufacturer's (Promega)
instructions. Protein concentrations of the lysates were determined by
the Lowry method. Fifty micrograms of protein was used for each assay.
CAT activity assays were performed using n-butyryl-coenzyme
A and [14C]chloramphenicol as substrates. Butyrylated
[14C]chloramphenicol was separated from free
chloramphenicol by xylene extraction. Labeled chloramphenicol was
quantified by scintillation counting on a Beckman LS 6000IC
scintillation counter.
Electrophoretic Mobility Shift Assays (EMSA)
Preparation of
crude nuclear protein extracts from cells and tissues and EMSA were
performed as described (10, 15) using the double-stranded
oligonucleotide probes shown in Fig. 5B. The SF-1 probe
sense strand sequence is 5 -GAGTTTTTCAAGGTCATGCTCAATTT-3 . The probes
were incubated with 10 µg of total nuclear protein or 2 µl of
in vitro transcribed/translated ERR . In vitro
transcription was performed with a human ERR cDNA template
generously provided by Dr. Christine Teng (National Institute of
Environmental Health Sciences). Double-stranded oligonucleotide probes
were 32P-labeled by Klenow "fill-in" of a 5 -GATC
overhang. Recombinant human ERR was produced using the TNT-coupled
reticulocyte lysate system (Promega) per the manufacturer's
instructions. Competition EMSA experiments were performed by addition
of a molar excess of unlabeled, unrelated, size-matched double-stranded
oligonucleotides or unlabeled NRRE-1 or NRRE-1 mutant oligonucleotides.
Antibody supershift experiments were performed with polyclonal
antibodies directed against human ERR (a gift from Dr. Vincent
Giguere, McGill University), COUP-TF I/II (MP33) and COUP-TF I (MP31)
(gifts from Dr. M. G. Parker, Imperial Cancer Research Fund), and
a mixture of monoclonal antibodies directed against RXR , - , -
(a gift from Dr. Pierre Chambon, Institut National de la Santé et
de la Recherche Médicale). Antibody supershift studies were
carried out by incubating the protein extract with preimmune serum or specific antibodies on ice for 15 min. The complete binding reaction mix including buffer, poly(dI·dC), and labeled probe were then added
to the extract and sera and incubated at room temperature for 20 min
before resolving on 5% non-denaturing polyacrylamide gel.
Fig. 5.
ERR binds NRRE-1 at sites 1 and 3. A, using EMSA, in vitro transcribed/translated
ERR (ERR lysate) was tested for its ability to bind
NRRE-1 and compared with the results with nuclear protein extracts
(NE) prepared from BAT and unprogrammed reticulocyte lysate
(Unprog. Lysate). ERR antibody (ERR
Ab) was added to lane 4 to confirm the presence of
ERR in the complex. B, sense-strand sequences of the
oligonucleotide probes used in the EMSA shown in C. The
location and relative orientation of the three potential hexameric
receptor binding half-sites within NRRE-1 are denoted by the
arrows. The single base pair substitutions in mutant probes
M1, M2, and M3 are underlined. C,
cross-competition (lanes 1-7) with 100-fold molar excess of
NRRE-1 (Sp), unrelated (NS), a known ERR
recognition site (SF1), or NRRE-1 mutants (M1, M2, and M3). In lanes 8-10,
32P-labeled wild-type (wt) M1, and
M3 probes were incubated with BAT nuclear protein extract
prepared from differentiated brown adipocytes.
[View Larger Version of this Image (30K GIF file)]
Western Blot Studies
Analysis was performed with 5 µg of
total nuclear protein lysate prepared from pre- and post-brown
adipocytes or mouse heart (embryonic day 20 and adult). For the tissue
expression panel, 10 µg of whole cell extract was used. Tissue
protein lysates were prepared by homogenization of the tissue in lysis
buffer (10 mM Tris, 5 mM EGTA, 0.1 mM dithiothreitol, 2 mM phenylmethylsulfonyl fluoride, 0.125 mg of leupeptin, and 0.5% SDS) followed by removal of
cellular debris by centrifugation at 15,000 × g. A
modification of the protein immunoblot analysis by Burnette (16) was
performed using the enhanced chemiluminescence detection system
(Amersham Corp.). The anti-ERR and anti-COUP-TF antibodies described
above were used. The anti-MCAD antibody has been described (17).
RESULTS
The Expression of Nuclear Genes Encoding Mitochondrial Fatty
Acid Oxidation Enzymes Is Induced during Brown Adipocyte
Differentiation To examine the expression of nuclear genes
involved in mitochondrial fatty acid -oxidation during brown
adipocyte differentiation, levels of mRNAs encoding enzymes
catalyzing the first (medium chain acyl-CoA dehydrogenase (MCAD) and
long chain acyl-CoA dehydrogenase) and third (3-hydroxy long chain
acyl-CoA dehydrogenase) steps of the mitochondrial -oxidation cycle
were delineated by RNA blot analysis. Expression of long chain
fatty-acyl-CoA synthetase, which catalyzes the thioesterification of
free fatty acids following cellular import was also analyzed. For these
experiments, primary pre-brown adipocytes were cultured following
isolation from the interscapular brown fat pad of 3-4-week-old
C57Bl/6xSJL mice. The pre-adipocytes were grown to confluency and
induced to differentiate using an established protocol described
previously (see Ref. 18 and "Materials and Methods"). Total RNA was
isolated from subconfluent pre-adipocytes and differentiated brown
adipocytes. The differentiated cells exhibited the morphological
characteristics typical of brown adipocytes including the appearance of
intracellular, multilocular lipid droplets and abundant, large
mitochondria. The levels of mRNA encoding long chain fatty-acyl-CoA
synthetase and the -oxidation cycle enzymes was markedly higher in
the differentiated brown adipocytes compared with that of the
pre-adipocytes (Fig. 1). Expression of
PPAR , a known marker for adipocyte differentiation (19), was also
induced confirming that the adipocyte program was activated in this
cell culture system.
Fig. 1.
Coordinate induction of the expression of
genes encoding mitochondrial -oxidation enzymes during brown
adipocyte differentiation. Autoradiogram of a representative
Northern blot analysis performed with total RNA isolated from murine
primary brown adipocytes grown in culture. RNA was isolated from cells
harvested at the pre-adipocyte stage (Pre) or from mature
brown adipocytes (Post). Using the differentiation protocol
described under "Materials and Methods," greater than 75% of the
cells were differentiated at the Post stage. 5 µg of total RNA was
loaded per lane. The blot was hybridized with the radiolabeled cDNA
probes denoted on the right. The 18 S ribosomal RNA signal
is shown as a control for loading. FACS, long chain
fatty-acyl-CoA synthetase.
[View Larger Version of this Image (42K GIF file)]
Transcriptional Activation of the MCAD Gene during Brown Adipocyte
Differentiation Requires a Nuclear Receptor Response Element
We
have shown previously that a 560-base pair human MCAD promoter fragment
fused to a chloramphenicol acetyltransferase reporter (MCADCAT.371) is
expressed at high levels in BAT in parallel with the endogenous MCAD
gene in adult transgenic mice (10). In contrast, expression of a
transgene (MCADCAT NRRE-1) that differs only in a 54-base pair
deletion of a region containing a known nuclear receptor response
element (NRRE-1) is not BAT-enriched (10). To determine whether the
induction of MCAD gene expression during brown adipocyte
differentiation occurs at the level of transcription and to define the
role of NRRE-1 in this regulation, transgene expression was
characterized during differentiation of pre-brown adipocytes isolated
from MCADCAT.371 and MCADCAT NRRE-1 mice. Transgene expression was
determined by measurement of CAT activity in lysates prepared from the
cultured cells at different time points following a switch to
differentiation media (see "Materials and Methods"). Day 0 represents the point at which the pre-adipocytes reached confluency. By
day 4 greater than 75% of the cells exhibited the mature brown
adipocyte phenotype as judged by the morphological characteristics
described under "Materials and Methods" and gene markers shown in
Fig. 1. CAT activity in the MCADCAT.371 cells increased markedly
(12-13 fold) upon differentiation (Fig.
2). This dramatic induction of CAT
activity corresponded with the appearance of immunodetectable
endogenous MCAD protein (Fig. 2). In contrast, expression of the
MCADCAT NRRE-1 transgene, which lacks NRRE-1, was unchanged during
differentiation of the cultured brown adipocytes (Fig. 2). These
results indicate that the induction of MCAD gene expression during
brown adipocyte differentiation occurs at the level of transcription
and requires the nuclear receptor response element, NRRE-1.
Fig. 2.
Induction of MCADCAT.371 transgene expression
during brown adipocyte differentiation. Primary brown adipocytes
were isolated from mice transgenic for MCADCAT.371 or MCADCAT NRRE-1, as described under "Materials and Methods." As shown in the
schematic at the bottom, NRRE-1 was deleted in the MCADCAT NRRE-1
construct (the numbers are relative to the transcription start
site = +1). The pre-brown adipocytes reached confluency on day 0. By day 4, greater than 75% of the cells were differentiated using the
criteria described under "Materials and Methods" and by the gene
markers shown in Fig. 1. CAT activity, normalized to levels at day 0, are shown for MCADCAT.371 and MCADCAT NRRE-1. The values represent mean (± S.E.) CAT activity from pooled cells from at least three independent experiments. The inset contains a representative
Western blot analysis (5 µg of total protein/lane) performed with an
anti-MCAD antibody using the protein extract samples used to determine
CAT activities.
[View Larger Version of this Image (17K GIF file)]
Identification of Brown Adipocyte Differentiation Stage-specific
NRRE-1 Binding Activities
Electrophoretic mobility shift assays
(EMSA) were performed to begin to characterize the transcription
factors involved in the induction of MCAD gene transcription during
brown adipocyte differentiation. For these experiments, an NRRE-1 probe
was incubated with nuclear protein extracts isolated from pre- and
post-brown adipocytes. As shown in Fig.
3A, distinct NRRE-1 binding
patterns were obtained with the two types of nuclear extracts. Two
complexes (pI and pII) of similar but distinct mobilities formed with
nuclear protein extracts prepared from pre-brown adipocytes. When the EMSA were performed with extracts prepared from the differentiated brown adipocytes, neither complex pI or pII was observed; rather two
new NRRE-1-protein complexes formed (dI and dII; Fig. 3A). dI was a faint, low mobility complex, and complex dII was a prominent complex migrating slightly faster than pI and pII. We have shown previously that NRRE-1-protein complexes of identical mobilities to
that of dI and dII also form with nuclear protein extracts prepared
from adult mouse heart and the brown adipocyte cell line HIB-1B (Ref.
10 and data not shown). Competition experiments performed with a molar
excess of specific (NRRE-1) or an unrelated, size-matched,
double-stranded oligonucleotide confirmed that all four complexes
represented specific NRRE-1/protein interactions (Fig. 3B).
These data identify brown adipocyte differentiation stage-specific
NRRE-1 binding activities and suggest that distinct transcription
factors interact with NRRE-1 during different stages of brown adipocyte
differentiation.
Fig. 3.
NRRE-1 interacts with pre- and post-brown
adipocyte nuclear proteins in a cell differentiation stage-specific
pattern. A, the results of EMSA performed with an NRRE-1
probe and nuclear proteins isolated from pre- and post-brown
adipocytes. Distinct NRRE-1-protein complexes pI and pII in the
pre-adipocytes and complexes dI and dII in the post-differentiated
adipocytes are labeled. B, results of EMSA competition
studies with the NRRE-1 probe and nuclear protein extracts prepared
from pre- and post-differentiated brown adipocytes. A 100-fold molar
excess of an unlabeled, unrelated size-matched double-stranded
oligonucleotide (NS) or 10-, 50-, or 100-fold molar excess
of an unlabeled NRRE-1 probe (ramp) were added to the incubation as
denoted at the top.
[View Larger Version of this Image (36K GIF file)]
The Orphan Nuclear Receptors, COUP-TF and ERR , Bind NRRE-1 in a
Brown Adipocyte Differentiation Stage-specific Manner
Antibody
recognition studies were performed to identify the proteins bound to
NRRE-1 in the complexes shown Fig. 3. A panel of antibodies raised
against various members of the nuclear receptor superfamily were used
in these studies. The initial studies focused on the protein-DNA
complexes (pI and pII) formed with the pre-adipocyte nuclear protein
extracts. Antibodies to RXR , PPAR , PPAR , thyroid receptor ,
and the orphan receptor, ERR , did not recognize proteins in complex
pI or pII (Fig. 4 and data not shown).
However, an anti-COUP-TF antibody that recognizes both COUP-TF I and
COUP-TF II isoforms (MP33; Ref. 20) abolished the formation of
complexes pI and pII (Fig. 4, lane 4). Addition of a COUP-TF
II-specific antibody (MP31) prevented the formation of complex pI but
not complex pII. Accordingly, complex pI and pII contain COUP-TF I and
II or closely related proteins. These data are consistent with the
results of our previous characterization of NRRE-1 demonstrating that
COUP-TF I, overproduced in bacteria, binds NRRE-1 (12). We have also
shown that overexpression of COUP-TF I in mammalian cell lines in
culture represses transcription of an MCAD promoter-reporter construct
via NRRE-1 (12).
Fig. 4.
Identification of COUP-TF and ERR in
NRRE-1-brown adipocyte nuclear protein complexes by antibody
recognition experiments. The autoradiographs depicted above
represent EMSA antibody recognition studies performed with an NRRE-1
probe and anti-ERR or anti-COUP-TF (MP31 and MP33) antibodies
(Ab). MP33 recognizes COUP-TF I and II, and MP31 is specific
for COUP-TF II. Preimmune (PI) serum was used to serve as a
negative control.
[View Larger Version of this Image (74K GIF file)]
The antibody EMSA studies were repeated with nuclear protein extracts
prepared from differentiated brown adipocytes. Initial studies focused
on the prominent NRRE-1-protein complex dII shown in Fig. 3. Previous
EMSA and cell cotransfection studies have demonstrated that
RXR /PPAR heterodimers bind NRRE-1 to activate transcription from
heterologous and homologous promoters (11). These results together with
the known role of PPAR in the adipocyte differentiation program
suggested that complex dII may contain PPAR/RXR heterodimers bound to
NRRE-1. Surprisingly, however, complex dII was not recognized by
anti-RXR , anti-PPAR , or anti-PPAR antibodies (data not shown).
The anti-COUP antibodies, MP31 and MP33, also failed to influence the
formation or mobility of complex dII (Fig. 4, lane 8).
However, an antibody to the orphan nuclear receptor ERR abolished
the formation of complex dII (Fig. 4, lane 9). Taken
together with the results shown above, these data strongly suggest that
the known transcriptional repressors COUP-TF I and II bind NRRE-1 to
silence MCAD gene expression in the pre-brown adipocyte but that during
brown adipocyte differentiation the orphan receptor ERR becomes the
predominant NRRE-1 binding protein.
Regarding the faint complex dI, none of the antibodies used above,
including the anti-COUP-TF antibodies, affected its formation or
mobility (data not shown). However, we have shown previously that
NRRE-1-protein complexes with mobilities identical to that of dI formed
with nuclear extracts prepared from adult mouse heart or HIB-1B cells
were recognized by a separate anti-COUP-TF antiserum raised to COUP-TF
I purified from HeLa cells (21). This antibody, which also prevented
the formation of complex dI (data not shown), has been shown to
recognize at least two other higher molecular weight proteins in
addition to COUP-TF I (21). Thus, we conclude that complex dI does not
contain COUP-TF I or COUP-TF II but may contain a structurally related
protein.
The MCAD ERR Recognition Site Requires Two Receptor Binding
Half-site Sequences Arranged as an Imperfect Everted Repeat
To
confirm that ERR binds NRRE-1, EMSA were performed with recombinant
ERR protein produced in an in vitro coupled reticulocyte lysate transcription/translation reaction. NRRE-1 formed a single prominent complex with the recombinant ERR but not with unprogrammed lysate (Fig. 5A, lanes 2 and
3). The mobility of the NRRE-1-recombinant ERR complex
was identical to that of the endogenous complex (complex dII) formed
with post-BAT nuclear protein extract (Fig. 5A, lanes 1 and
3). Addition of anti-ERR antibody prevented the formation of the recombinant ERR ·NRRE-1 complex demonstrating the presence of ERR (Fig. 5A, lane 4). These results confirm that
NRRE-1 contains an ERR recognition site. Moreover, the similar
mobilities of complex dII and the NRRE-1-recombinant ERR complex
suggests that complex dII contains only ERR .
NRRE-1 is a novel, pleiotropic element composed of three potential
nuclear receptor binding half-site sequences (shown in Fig.
5B). We have shown previously (12) that the unique
arrangement of the hexameric receptor binding half-sites within NRRE-1
dictates three potential receptor dimer binding elements; an everted
imperfect repeat separated by 13 bases (ER-13, sites 1 and 3), an ER-8
(sites 1 and 2), and an imperfect direct repeat (DR-O, sites 2 and 3). To define the ERR binding site requirements within NRRE-1, EMSA competition studies were performed. Recombinant ERR protein was used
for these studies. As expected, a molar excess of unlabeled NRRE-1
prevented formation of the NRRE-1·ERR complex, whereas an
identical molar excess of a nonspecific, size-matched probe had no
effect on its formation (Fig. 5C, lanes 1-3). Previous studies by others (22) have demonstrated that ERR binds with high
affinity to the extended half-site sequence, 5 -TCAAGGTCA-3 , present
in the steroidogenic factor 1 (SF-1) consensus binding site. A probe
containing the SF-1 site was also efficient at preventing the
ERR ·NRRE-1 complex formation (Fig. 5B, lane 4). To
define the NRRE-1 binding sites necessary for ERR binding,
competition studies were performed with mutated NRRE-1 oligonucleotide
fragments containing G to C substitutions at the invariant second
position within each of the three potential receptor binding half-sites (sequences are shown in Fig. 5B). Although the NRRE-1 site 2 mutant (M2) was capable of competing with NRRE-1, the site 1 (M1) and site 3 (M3) mutants did not prevent complex formation (Fig. 5C, lanes 5-7). These results suggest that ERR interacts with
sites 1 and 3 within NRRE-1. Finally, to determine whether NRRE-1 sites 1 and 3 were required for the interaction of NRRE-1 with endogenous ERR , nuclear protein extracts prepared from differentiated brown adipocytes were incubated with radiolabeled NRRE-1, M1, or M3 probes.
The ERR ·NRRE-1 complex did not form with the M1 probe and was
markedly diminished with the M3 probe (Fig. 5A, lanes 12-14). Taken together, these data indicate that ERR binds
NRRE-1 sites 1 and 3, possibly as a dimer. Of note, we have shown
previously that recombinant COUP-TF I homodimers bind NRRE-1 at sites 1 and 3 (12) and that this complex co-migrates with complex pII (data not
shown).
Expression of ERR Parallels Expression of the MCAD Gene during
BAT Differentiation and among Murine Tissues
The results shown
above implicate ERR in the control of nuclear genes encoding MCAD
and other mitochondrial fatty acid oxidation enzymes during brown
adipocyte differentiation. To determine whether the nuclear expression
of ERR parallels its NRRE-1 binding activity and MCAD expression
during differentiation of the brown adipocyte, Western blot studies
were performed with nuclear protein extracts prepared from pre- and
post-adipocytes. Steady-state nuclear levels of ERR were markedly
induced during the transition from pre- to post-brown adipocyte (Fig.
6A). The induction of ERR
expression during brown adipocyte differentiation paralleled MCAD
protein levels (Fig. 6A), the transcriptional activity of
the MCADCAT.371 transgene (Fig. 2), and NRRE-1 binding activities (Fig.
3). In contrast, COUP-TF was expressed in a reciprocal pattern during adipocyte differentiation as predicted by NRRE-1 binding activity (Fig.
3) and the known role of COUP-TF as a transcriptional repressor of the
MCAD gene (12).
Fig. 6.
Expression patterns of ERR and COUP-TF
compared with MCAD. A, Western blot analysis using
anti-ERR and anti-COUP-TF antisera with nuclear protein extracts
prepared from pre- and post-differentiated brown adipocytes
(BAT) and embryonic day 20 (e20) and adult mouse
heart. Whole cell protein extracts were used to determine steady-state
MCAD levels. Each lane contains 5 µg of total protein. B,
Western blot analysis of ERR compared with MCAD in whole cell
protein extracts prepared from a variety of adult murine tissues. Each
lane contains 10 µg of total cellular protein.
[View Larger Version of this Image (49K GIF file)]
ERR and COUP-TF expression was also examined in the perinatal
developing heart. The expression of mitochondrial fatty acid -oxidation enzymes is known to be markedly induced in heart
following birth as the chief myocardial energy substrate switches from
glucose to fatty acids. Levels of ERR were induced from the fetal
(embryonic day 20) to adult mouse heart in parallel with MCAD protein
levels, whereas COUP-TF expression followed a reciprocal pattern (Fig. 6A). These results implicate ERR and COUP-TF in the
differential transcriptional control of nuclear genes involved in
mitochondrial -oxidation during brown adipocyte differentiation and
perinatal cardiac development.
The expression of ERR was also delineated in a variety of adult
mouse tissues with distinct capacities for mitochondrial fatty acid
oxidation. The tissue expression pattern of ERR was compared with
that of MCAD. ERR expression was greatest in tissues with high
capacity for fatty acid oxidation and abundant expression of MCAD, such
as BAT and heart (Fig. 6B). In contrast, ERR expression was low in white adipose tissue, brain, and lung, tissues with low
-oxidation rates. These data suggest that in addition to the control
of -oxidation enzyme expression during adipocyte differentiation and
perinatal cardiac development, ERR plays a role in the expression of
mitochondrial -oxidation enzymes among adult mammalian tissues.
DISCUSSION
The molecular regulatory mechanisms involved in the commitment to
separate brown and white adipocyte differentiation programs are
presently unknown. One of the major biochemical differences between
white and brown adipose tissue is the level of mitochondrial fatty acid
-oxidation. Although the white adipocyte is a storage depot for
fatty acids, the brown adipocyte actively metabolizes fatty acids to
produce reducing equivalents for the mitochondrial uncoupling reaction.
Differentiation of the brown adipocyte leads to a marked increase in
the expression of nuclear genes encoding mitochondrial fatty acid
-oxidation enzymes coincident with a dramatic increase in the size
and number of mitochondria. We sought to define the transcriptional
regulatory pathway responsible for high level expression of fatty acid
oxidation enzyme genes in BAT as an initial step in the elucidation of
the brown adipocyte gene regulatory program. In this report, we provide
evidence for the role of two orphan nuclear receptors, COUP-TF and
ERR , in the transcriptional control of a pivotal -oxidation
enzyme gene during brown adipocyte differentiation.
The mitochondrial UCP, a distinctive and specific marker for the brown
adipocyte, has been a major focus of investigation of BAT gene
expression. Characterization of the UCP promoter has implicated several
transcription factors that appear to interact in a complex manner to
direct high level UCP gene expression. Among these factors are CREBP
(23), RXR/TR (24), Ets1 (24), and RXR/PPAR (25). To our knowledge,
none of these transcription factors exhibit BAT-enriched expression.
Recently, we have identified a region of human MCAD gene promoter that
is necessary for high level BAT expression in transgenic mice (10). The
nuclear receptor response element, NRRE-1, is located within this MCAD
gene promoter region. Previous studies performed in cell culture have
shown that NRRE-1 is a pleiotropic nuclear receptor responsive element capable of conferring transcriptional activation by RXR/PPAR heterodimers or repression by COUP-TF homodimers (11, 12). Surprisingly, we did not detect RXR or PPAR in the NRRE-1-protein complexes formed with crude nuclear protein extracts prepared from pre-
or post-differentiated brown adipocytes. Rather, a switch in NRRE-1
binding from COUP-TF to ERR was identified during the transition
from pre- to post-differentiated brown adipocyte. In contrast to other
factors shown previously to interact with the MCAD and UCP promoters,
ERR is expressed in a BAT-enriched pattern. Nuclear levels of ERR
increase markedly during brown adipocyte differentiation. Moreover,
ERR expression is significantly higher in BAT compared with white
adipose tissue. Accordingly, we propose that ERR is a candidate
regulator of the brown adipocyte mitochondrial -oxidation
pathway.
Our observation that COUP-TF interacts with NRRE-1 in nuclear extracts
prepared from the pre-brown adipocyte is consistent with its known role
as a transcriptional repressor. We have shown previously that COUP-TF
is a potent repressor of MCAD gene transcription and is capable of
silencing retinoid-mediated transcriptional activation via NRRE-1 (12,
26). In this report we demonstrate that COUP-TF expression is highest
in the pre-adipocyte, falling during differentiation. Taken together,
these data strongly suggest that COUP-TF silences the expression of the
MCAD gene in the pre-adipocyte.
ERR was originally identified in a screen of a testis cDNA
library with the estrogen receptor DNA binding domain (27). To date,
few true targets for ERR have been identified. ERR response
elements have been identified within the SV40 late promoter (28) and
the human lactoferrin promoter (29). More recently, ERR has been
shown to activate transcription from the bone-specific osteopontin
promoter in cell culture studies (30). The expression pattern of ERR
is consistent with a role for the receptor in bone development (30).
Our ERR expression studies are consistent with the NRRE-1 binding
data and strongly suggest that genes involved in mitochondrial
fatty acid oxidation are targets for ERR . ERR expression is
induced during brown adipocyte differentiation and following birth in
heart, in parallel with fatty acid oxidation rates and expression of
-oxidation enzymes (10, 14, 31). Furthermore, the expression of
ERR among adult murine tissues parallels MCAD expression with
abundant levels in tissues with high fatty acid utilization rates (BAT
and heart) and low expression in less oxidative tissues such as white
adipose and brain. The actual role of ERR in the transcriptional
control of MCAD and other -oxidation enzymes in vivo
remains unknown. We have shown previously in cell culture studies that
MCAD gene transcription is activated by PPAR in the presence of
fatty acids or inhibitors of carnitine palmitoyltransferase I, known
ligands for this nuclear receptor (11, 32, 33). Our results do not
exclude the possibility that PPAR is a regulator of MCAD gene
expression under certain circumstances in vivo. It is also
tempting to speculate that a metabolite ligand exists for ERR . The
precise function of PPAR and ERR in the expression of genes
encoding MCAD and other mitochondrial -oxidation enzymes in
vivo will require further investigation.
All ERR recognition sites identified to date are extended half-site
sequences similar to the SF-1 response element, 5 -TCAAGGTCA-3 , to
which ERR binds as a monomer (22). Our results demonstrate that
NRRE-1 binding sites 1 and 3 (Fig. 5B) are required for the NRRE-1/ERR interaction. Indeed, the extended sequences of sites 1 (5 -GAAAGGTCA-3 ) and 3 (5 -TAAAGGTGA-3 ) are similar to the known
ERR binding consensus. In contrast, NRRE-1 site 2 (5 -TCCGGGTAA-3 ), which is not required for ERR binding, does not conform to the consensus. Our mutational EMSA studies indicate that both sites 1 and 3 are necessary for the NRRE-1/ERR interaction. These results suggest
that in contrast to previously defined ERR targets, ERR may bind
NRRE-1 as a homodimer to the everted imperfect repeat comprised of
sites 1 and 3. However, our data do not exclude the possibility that
independent ERR monomers bind NRRE-1 sites 1 and 3 in a cooperative
manner.
In summary, we have demonstrated that the transcriptional induction of
a nuclear gene encoding a key mitochondrial fatty acid -oxidation
cycle enzyme during brown adipocyte differentiation requires the
pleiotropic nuclear receptor response element, NRRE-1. The orphan
nuclear receptors, COUP-TF and ERR , were shown to bind NRRE-1 in a
brown adipocyte differentiation stage-specific manner. These results
implicate ERR in the brown adipocyte gene regulatory program and
identify genes involved in mitochondrial fatty acid oxidation as
potential ERR targets.
FOOTNOTES
*
This work was supported by National Institutes of Health
Grant RO1-DK45416.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Center for
Cardiovascular Research, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8086, St. Louis, MO 63110. Tel.: 314-362-8908; Fax: 314-362-0186; E-mail:
dkelly{at}imgate.wustl.edu.
1
The abbreviations used are: UCP, uncoupling
protein; MCAD, medium chain acyl-coenzyme A dehydrogenase; EMSA,
electrophoretic mobility shift assays; NRRE, nuclear receptor response
element; ERR , estrogen-related receptor ; BAT, brown adipose
tissue; PPAR , peroxisome proliferator-activated receptor ; RXR,
retinoid X receptor; COUP-TF, chicken ovalbumin upstream promoter
transcription factor; CAT, chloramphenicol acetyltransferase.
ACKNOWLEDGEMENTS
We thank Dr. Daniel Ricquier for helpful
advice concerning the primary brown adipocyte culture system, Dr.
Jeffrey Saffitz for assistance in electron microscopic characterization
of the adipocytes, and Kelly Hall for expert secretarial
assistance.
Note Added in Proof
During review of this manuscript, Sladek
et al. (34) described the regulation of MCAD gene expression by ERR .
REFERENCES
-
Lowell, B. B., S-, Susulic, V., Hamann, A., Lawitts, J. A., Himms-Hagen, J., Boyer, B. B., Kozak, L. P., and Flier, J. S.
(1993)
Nature
366,
740-742
[CrossRef][Medline]
[Order article via Infotrieve]
-
Fluery, C., Neverova, M., Collins, S., Raimbault, S., Champigny, O., Levi-Meyrueis, C., Bouillaud, F., Seldin, M. F., Surwit, R. S., Ricquier, D., and Warden, C. H.
(1997)
Nat. Genet.
15,
269-272
[CrossRef][Medline]
[Order article via Infotrieve]
-
Vidalpuig, A., Solanes, G., Grujic, D., Flier, J. S., and Lowell, B. B.
(1997)
Biochem. Biophys. Res. Commun.
235,
79-82
[CrossRef][Medline]
[Order article via Infotrieve]
-
Boss, O., Samec, S., Paolonigiacobino, A., Rossier, C., Dulloo, A., Seydoux, J., Muzzin, P., and Giacobino, J. P.
(1997)
FEBS Lett.
408,
39-42
[CrossRef][Medline]
[Order article via Infotrieve]
-
Beinert, H.
(1963)
in
The Enzymes (Boyer, P. D., Lardy, H. J., and Myrbock, K., eds), pp. 447-476, Academic Press, Inc., New York
-
Tontonoz, P., Hu, E., and Spiegelman, B. M.
(1995)
Cell
79,
1147-1156
-
Hu, E., Tonotonoz, P., and Spiegelman, B. M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9856-9860
[Abstract/Free Full Text]
-
Wang, N., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., and Darlington, G. J.
(1995)
Science
269,
1108-1112
[Abstract/Free Full Text]
-
Wu, Z., Xie, Y., Bucher, N. L. R., and Farmer, S. R.
(1995)
Genes Dev.
9,
2350-2363
[Abstract/Free Full Text]
-
Disch, D. L., Rader, T. A., Cresci, S., Leone, T. C., Barger, P. H., Vega, R., Wood, P. A., and Kelly, D. P.
(1996)
Mol. Cell. Biol.
16,
4043-4051
[Abstract]
-
Gulick, T., Cresci, S., Caira, T., Moore, D. D., and Kelly, D. P.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
11012-11016
[Abstract/Free Full Text]
-
Carter, M. E., Gulick, T., Moore, D. D., and Kelly, D. P.
(1994)
Mol. Cell. Biol.
14,
4360-4372
[Abstract/Free Full Text]
-
Nechad, M., Kuusela, P., Carneheim, C., Bjorntrop, P., Nedergaard, J., and Cannon, B.
(1983)
Exp. Cell Res.
149,
105-118
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kelly, D. P., Gordon, J. I., Alpers, R., and Strauss, A. W.
(1989)
J. Biol. Chem.
264,
18921-18925
[Abstract/Free Full Text]
-
Revzin, A.
(1989)
BioTechniques
7,
346-355
[Medline]
[Order article via Infotrieve]
-
Burnette, W. N.
(1981)
Anal. Biochem.
112,
195-203
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kelly, D. P., Kim, J. J., Billadello, J. J., Hainline, B. E., Chu, T. W., and Strauss, A. W.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
84,
4068-4072
-
Cassard-Doulcier, A.-M., Gelly, C., Fox, N., Schrementi, J., Raimbault, S., Klaus, S., Forest, C., Bouillaud, F., and Ricquier, D.
(1993)
Mol. Endocrinol.
7,
497-506
[Abstract/Free Full Text]
-
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., and Spiegelman, B. M.
(1994)
Genes Dev.
8,
1224-1234
[Abstract/Free Full Text]
-
Butler, A. J., and Parker, M. G.
(1995)
Nucleic Acids Res.
23,
4143-4150
[Abstract/Free Full Text]
-
Wang, L., Tsai, S. Y., Cook, R. G., Beattie, W. G., Tsai, M., and O'Malley, B. W.
(1989)
Nature
340,
163-166
[CrossRef][Medline]
[Order article via Infotrieve]
-
Johnston, S. D., Liu, X., Zuo, F., Eisenbraun, T. L., Wiley, S. R., Kraus, R. J., and Mertz, J. E.
(1997)
Mol. Endocrinol.
11,
342-352
[Abstract/Free Full Text]
-
Kozak, U. C., Kopecky, J., Teisinger, J., Enerback, S., Boyer, B., and Kozak, L. P.
(1994)
Mol. Cell. Biol.
14,
59-67
[Abstract/Free Full Text]
-
Cassard-Doulcier, A. M., Larose, M., Matamala, J. C., Champigny, O., Bouillaud, F., and Ricquier, D.
(1994)
J. Biol. Chem.
269,
24335-24342
[Abstract/Free Full Text]
-
Sears, I. B., MacGinnitie, M. A., Kovacs, L. G., and Graves, R. A.
(1996)
Mol. Cell. Biol.
16,
3410-3419
[Abstract]
-
Sack, M. N., Disch, D., Rockman, H., and Kelly, D. P.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
6438-6443
[Abstract/Free Full Text]
-
Giguere, V., Yang, N., Segui, P., and Evans, R. M.
(1988)
Nature
331,
91-94
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zuo, F., and Mertz, J. E.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8586-8590
[Abstract/Free Full Text]
-
Yang, N., Shigeta, H., Shi, H., and Teng, C. T.
(1996)
J. Biol. Chem.
271,
5795-5804
[Abstract/Free Full Text]
-
Bonnelye, E., Vanacker, J. M., Dittmar, T., Begue, A., Desbiens, X., Denhardt, D. T., Augin, J. E., Laudet, V., and Fournier, B.
(1997)
Mol. Endocrinol.
11,
905-916
[Abstract/Free Full Text]
-
Bremer, J., and Osmundsen, H.
(1984)
in
Fatty Acid Oxidation and Its Regulation (Numa, S., ed), pp. 13-154, Elsevier Science Publishers, B. V., Amsterdam
-
Forman, B. M., Chen, J., and Evans, R. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
4312-4317
[Abstract/Free Full Text]
-
Krey, G., Braissant, O., O'Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., and Wahli, W.
(1997)
Mol. Endocrinol.
11,
779-791
[Abstract/Free Full Text]
-
Sladek, R., Bader, J.-A., and Giguere, V.
(1997)
Mol. Cell. Biol.
17,
5400-5409
[Abstract]
Volume 272, Number 50,
Issue of December 12, 1997
pp. 31693-31699
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Chisamore, H. A. Wilkinson, O. Flores, and J. D. Chen
Estrogen-related receptor-{alpha} antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts
Mol. Cancer Ther.,
March 1, 2009;
8(3):
672 - 681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Giguere
Transcriptional Control of Energy Homeostasis by the Estrogen-Related Receptors
Endocr. Rev.,
October 1, 2008;
29(6):
677 - 696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hummasti and P. Tontonoz
Adopting New Orphans into the Family of Metabolic Regulators
Mol. Endocrinol.,
August 1, 2008;
22(8):
1743 - 1753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Tremblay, B. J. Wilson, X.-J. Yang, and V. Giguere
Phosphorylation-Dependent Sumoylation Regulates Estrogen-Related Receptor-{alpha} and -{gamma} Transcriptional Activity through a Synergy Control Motif
Mol. Endocrinol.,
March 1, 2008;
22(3):
570 - 584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Mst. H. Akter, T. Chano, H. Okabe, T. Yamaguchi, F. Hirose, and T. Osumi
Target Specificities of Estrogen Receptor-Related Receptors: Analysis of Binding Sequences and Identification of Rb1-Inducible Coiled-Coil 1 (Rb1cc1) as a Target Gene
J. Biochem.,
March 1, 2008;
143(3):
395 - 406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sonoda, J. Laganiere, I. R. Mehl, G. D. Barish, L.-W. Chong, X. Li, I. E. Scheffler, D. C. Mock, A. R. Bataille, F. Robert, et al.
Nuclear receptor ERR{alpha} and coactivator PGC-1beta are effectors of IFN-{gamma}-induced host defense
Genes & Dev.,
August 1, 2007;
21(15):
1909 - 1920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Spector, Y. Yarden, B. Smith, L. Lyass, P. Trusk, K. Pry, J. E. Hill, W. Xia, R. Seger, and S. S. Bacus
Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells
PNAS,
June 19, 2007;
104(25):
10607 - 10612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bonnelye, R. A. Zirngibl, P. Jurdic, and J. E. Aubin
The Orphan Nuclear Estrogen Receptor-Related Receptor-{alpha} Regulates Cartilage Formation in Vitro: Implication of Sox9
Endocrinology,
March 1, 2007;
148(3):
1195 - 1205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Villena, M. B. Hock, W. Y. Chang, J. E. Barcas, V. Giguere, and A. Kralli
Orphan nuclear receptor estrogen-related receptor {alpha} is essential for adaptive thermogenesis
PNAS,
January 23, 2007;
104(4):
1418 - 1423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Nichol, M. Christian, J. H. Steel, R. White, and M. G. Parker
RIP140 Expression Is Stimulated by Estrogen-related Receptor {alpha} during Adipogenesis
J. Biol. Chem.,
October 27, 2006;
281(43):
32140 - 32147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Rodriguez-Calvo, M. Jove, T. Coll, A. Camins, R. M. Sanchez, M. Alegret, M. Merlos, M. Pallas, J. C. Laguna, and M. Vazquez-Carrera
PGC-1{beta} Down-Regulation Is Associated With Reduced ERR{alpha} Activity and MCAD Expression in Skeletal Muscle of Senescence-Accelerated Mice.
J. Gerontol. A Biol. Sci. Med. Sci.,
August 1, 2006;
61(8):
773 - 780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zhang, K. Chen, J. C. Shih, and C. T. Teng
Estrogen-Related Receptors-Stimulated Monoamine Oxidase B Promoter Activity Is Down-Regulated by Estrogen Receptors
Mol. Endocrinol.,
July 1, 2006;
20(7):
1547 - 1561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Barry, J. Laganiere, and V. Giguere
A Single Nucleotide in an Estrogen-Related Receptor {alpha} Site Can Dictate Mode of Binding and Peroxisome Proliferator-Activated Receptor {gamma} Coactivator 1{alpha} Activation of Target Promoters
Mol. Endocrinol.,
February 1, 2006;
20(2):
302 - 310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Herzog, J. Cardenas, R. K. Hall, J. A. Villena, P. J. Budge, V. Giguere, D. K. Granner, and A. Kralli
Estrogen-related Receptor {alpha} Is a Repressor of Phosphoenolpyruvate Carboxykinase Gene Transcription
J. Biol. Chem.,
January 6, 2006;
281(1):
99 - 106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Kim, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld
Suppression of estrogen-related receptor {alpha} and medium-chain acyl-coenzyme A dehydrogenase in the acute-phase response
J. Lipid Res.,
October 1, 2005;
46(10):
2282 - 2288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E E Connor, D L Wood, T S Sonstegard, A F da Mota, G L Bennett, J L Williams, and A V Capuco
Chromosomal mapping and quantitative analysis of estrogen-related receptor alpha-1, estrogen receptors alpha and beta and progesterone receptor in the bovine mammary gland
J. Endocrinol.,
June 1, 2005;
185(3):
593 - 603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S. J. de Souza, A. M. Santangelo, V. Bumaschny, M. E. Avale, J. L. Smart, M. J. Low, and M. Rubinstein
Identification of Neuronal Enhancers of the Proopiomelanocortin Gene by Transgenic Mouse Analysis and Phylogenetic Footprinting
Mol. Cell. Biol.,
April 15, 2005;
25(8):
3076 - 3086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Liu, Z Zhang, and C T Teng
Estrogen-related receptor-{gamma} and peroxisome proliferator-activated receptor-{gamma} coactivator-1{alpha} regulate estrogen-related receptor-{alpha} gene expression via a conserved multi-hormone response element
J. Mol. Endocrinol.,
April 1, 2005;
34(2):
473 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Cheung, S. Yu, K. B. Wong, L. W. Chan, F. M. M. Lai, X. Wang, M. Suetsugi, S. Chen, and F. L. Chan
Expression and Functional Study of Estrogen Receptor-Related Receptors in Human Prostatic Cells and Tissues
J. Clin. Endocrinol. Metab.,
March 1, 2005;
90(3):
1830 - 1844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Carrier, G. Deblois, C. Champigny, E. Levy, and V. Giguere
Estrogen-related Receptor {alpha} (ERR{alpha}) Is a Transcriptional Regulator of Apolipoprotein A-IV and Controls Lipid Handling in the Intestine
J. Biol. Chem.,
December 10, 2004;
279(50):
52052 - 52058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Huss, I. P. Torra, B. Staels, V. Giguere, and D. P. Kelly
Estrogen-Related Receptor {alpha} Directs Peroxisome Proliferator-Activated Receptor {alpha} Signaling in the Transcriptional Control of Energy Metabolism in Cardiac and Skeletal Muscle
Mol. Cell. Biol.,
October 15, 2004;
24(20):
9079 - 9091.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B Horard, A Castet, P-L Bardet, V Laudet, V Cavailles, and J-M Vanacker
Dimerization is required for transactivation by estrogen-receptor-related (ERR) orphan receptors: evidence from amphioxus ERR
J. Mol. Endocrinol.,
October 1, 2004;
33(2):
493 - 509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Huss and D. P. Kelly
Nuclear Receptor Signaling and Cardiac Energetics
Circ. Res.,
September 17, 2004;
95(6):
568 - 578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Willy, I. R. Murray, J. Qian, B. B. Busch, W. C. Stevens Jr., R. Martin, R. Mohan, S. Zhou, P. Ordentlich, P. Wei, et al.
Regulation of PPAR{gamma} coactivator 1{alpha} (PGC-1{alpha}) signaling by an estrogen-related receptor {alpha} (ERR{alpha}) ligand
PNAS,
June 15, 2004;
101(24):
8912 - 8917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Laganiere, G. B. Tremblay, C. R. Dufour, S. Giroux, F. Rousseau, and V. Giguere
A Polymorphic Autoregulatory Hormone Response Element in the Human Estrogen-related Receptor {alpha} (ERR{alpha}) Promoter Dictates Peroxisome Proliferator-activated Receptor {gamma} Coactivator-1{alpha} Control of ERR{alpha} Expression
J. Biol. Chem.,
April 30, 2004;
279(18):
18504 - 18510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N. Schreiber, R. Emter, M. B. Hock, D. Knutti, J. Cardenas, M. Podvinec, E. J. Oakeley, and A. Kralli
The estrogen-related receptor {alpha} (ERR{alpha}) functions in PPAR{gamma} coactivator 1{alpha} (PGC-1{alpha})-induced mitochondrial biogenesis
PNAS,
April 27, 2004;
101(17):
6472 - 6477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Kelly and R. C. Scarpulla
Transcriptional regulatory circuits controlling mitochondrial biogenesis and function
Genes & Dev.,
February 15, 2004;
18(4):
357 - 368.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. CANNON and J. NEDERGAARD
Brown Adipose Tissue: Function and Physiological Significance
Physiol Rev,
January 1, 2004;
84(1):
277 - 359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Luo, R. Sladek, J. Carrier, J.-A. Bader, D. Richard, and V. Giguere
Reduced Fat Mass in Mice Lacking Orphan Nuclear Receptor Estrogen-Related Receptor {alpha}
Mol. Cell. Biol.,
November 15, 2003;
23(22):
7947 - 7956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Liu, Z. Zhang, W. Gladwell, and C. T. Teng
Estrogen Stimulates Estrogen-Related Receptor {alpha} Gene Expression through Conserved Hormone Response Elements
Endocrinology,
November 1, 2003;
144(11):
4894 - 4904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kamei, H. Ohizumi, Y. Fujitani, T. Nemoto, T. Tanaka, N. Takahashi, T. Kawada, M. Miyoshi, O. Ezaki, and A. Kakizuka
PPAR{gamma} coactivator 1{beta}/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity
PNAS,
October 14, 2003;
100(21):
12378 - 12383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rhee, Y. Inoue, J. C. Yoon, P. Puigserver, M. Fan, F. J. Gonzalez, and B. M. Spiegelman
Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): Requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis
PNAS,
April 1, 2003;
100(7):
4012 - 4017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N. Schreiber, D. Knutti, K. Brogli, T. Uhlmann, and A. Kralli
The Transcriptional Coactivator PGC-1 Regulates the Expression and Activity of the Orphan Nuclear Receptor Estrogen-Related Receptor alpha (ERRalpha )
J. Biol. Chem.,
March 7, 2003;
278(11):
9013 - 9018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ichida, S. Nemoto, and T. Finkel
Identification of a Specific Molecular Repressor of the Peroxisome Proliferator-activated Receptor gamma Coactivator-1 alpha (PGC-1alpha )
J. Biol. Chem.,
December 20, 2002;
277(52):
50991 - 50995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Huss, R. P. Kopp, and D. P. Kelly
Peroxisome Proliferator-activated Receptor Coactivator-1alpha (PGC-1alpha ) Coactivates the Cardiac-enriched Nuclear Receptors Estrogen-related Receptor-alpha and -gamma . IDENTIFICATION OF NOVEL LEUCINE-RICH INTERACTION MOTIF WITHIN PGC-1alpha
J. Biol. Chem.,
October 18, 2002;
277(43):
40265 - 40274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bonnelye, V. Kung, C. Laplace, D. L. Galson, and J. E. Aubin
Estrogen Receptor-Related Receptor {alpha} Impinges on the Estrogen Axis in Bone: Potential Function in Osteoporosis
Endocrinology,
September 1, 2002;
143(9):
3658 - 3670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Kraus, E. A. Ariazi, M. L. Farrell, and J. E. Mertz
Estrogen-related Receptor alpha 1 Actively Antagonizes Estrogen Receptor-regulated Transcription in MCF-7 Mammary Cells
J. Biol. Chem.,
June 28, 2002;
277(27):
24826 - 24834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J.-A. Gustafsson
Mechanisms of Estrogen Action
Physiol Rev,
October 1, 2001;
81(4):
1535 - 1565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lu, Y. Kiriyama, K. Y. Lee, and V. Giguere
Transcriptional Regulation of the Estrogen-inducible pS2 Breast Cancer Marker Gene by the ERR Family of Orphan Nuclear Receptors
Cancer Res.,
September 1, 2001;
61(18):
6755 - 6761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Coward, D. Lee, M. V. Hull, and J. M. Lehmann
4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma
PNAS,
July 5, 2001;
(2001)
151244398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bonnelye, L. Merdad, V. Kung, and J.E. Aubin
The Orphan Nuclear Estrogen Receptor-related Receptor {alpha} (ERR{alpha}) Is Expressed throughout Osteoblast Differentiation and Regulates Bone Formation In Vitro
J. Cell Biol.,
May 21, 2001;
153(5):
971 - 984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Penfornis, S. Viengchareun, D. Le Menuet, F. Cluzeaud, M.-C. Zennaro, and M. Lombes
The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes
Am J Physiol Endocrinol Metab,
August 1, 2000;
279(2):
E386 - E394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Giguère
Orphan Nuclear Receptors: From Gene to Function
Endocr. Rev.,
October 1, 1999;
20(5):
689 - 725.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Cresci, M. L. Clabby, and D. P. Kelly
Evidence for a Novel Cardiac-enriched Retinoid X Receptor Partner
J. Biol. Chem.,
September 3, 1999;
274(36):
25668 - 25674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zhang and C. T. Teng
Estrogen Receptor-related Receptor alpha 1 Interacts with Coactivator and Constitutively Activates the Estrogen Response Elements of the Human Lactoferrin Gene
J. Biol. Chem.,
June 30, 2000;
275(27):
20837 - 20846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Coward, D. Lee, M. V. Hull, and J. M. Lehmann
4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma
PNAS,
July 17, 2001;
98(15):
8880 - 8884.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|